Protein O-GlcNAcylation in diabetes and diabetic complications.
about
Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its ComplicationsHyperglycemic Stress and Carbon Stress in Diabetic GlucotoxicityYou are what you eat: O-linked N-acetylglucosamine in disease, development and epigeneticsCurrent strategies and findings in clinically relevant post-translational modification-specific proteomicsPost-translational modifications of the cardiac proteome in diabetes and heart failurePathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress.O-GlcNAcylation, contractile protein modifications and calcium affinity in skeletal muscle.X marks the spot: does it matter that O-GlcNAc transferase is an X-linked gene?O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells.The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells.O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.The Role of PTP1B O-GlcNAcylation in Hepatic Insulin ResistanceSenescence-Associated Changes in Proteome and O-GlcNAcylation Pattern in Human Peritoneal Mesothelial CellsDisease, Models, Variants and Altered Pathways-Journeying RGD Through the Magnifying Glass.Isotope Targeted Glycoproteomics (IsoTaG) to Characterize Intact, Metabolically Labeled Glycopeptides from Complex Proteomes.Glycomics and glycoproteomics of membrane proteins and cell-surface receptors: Present trends and future opportunities.A Novel Quantitative Mass Spectrometry Platform for Determining Protein O-GlcNAcylation Dynamics.System-based proteomic and metabonomic analysis of the Df(16)A+/- mouse identifies potential miR-185 targets and molecular pathway alterationsRegulation of cancer metabolism by O-GlcNAcylation.The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc.O-GlcNAc profiling: from proteins to proteomes.Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation.Role of O-GlcNAcylation in nutritional sensing, insulin resistance and in mediating the benefits of exercise.Detection and identification of O-GlcNAcylated proteins by proteomic approaches.O-GlcNAcylation Links ChREBP and FXR to Glucose-SensingThe Utilities of Chemical Reactions and Molecular Tools for O-GlcNAc Proteomic Studies.O-GlcNAcylation of the human epidermal growth factor receptor.O-GlcNAc modification is essential for the regulation of autophagy in Drosophila melanogaster.Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.Increased O-GlcNAcylation of NF-κB Enhances Retinal Ganglion Cell Death in Streptozotocin-induced Diabetic Retinopathy.Detecting O-GlcNAc using in vitro sulfationNeuCode Proteomics Reveals Bap1 Regulation of Metabolism.Mass spectrometric analysis of the cell surface N-glycoproteome by combining metabolic labeling and click chemistry.Development of IsoTaG, a Chemical Glycoproteomics Technique for Profiling Intact N- and O-Glycopeptides from Whole Cell Proteomes.Augmented O-GlcNAcylation of AMP-activated kinase promotes the proliferation of LoVo cells, a colon cancer cell line.Detection of O-Linked-N-Acetylglucosamine Modification and Its Associated Enzymes in Human Degenerated Intervertebral Discs.A Sweet Embrace: Control of Protein-Protein Interactions by O-Linked β-N-Acetylglucosamine.Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase.Structures of human O-GlcNAcase and its complexes reveal a new substrate recognition mode.Lipopolysaccharide (LPS)-stimulated iNOS Induction Is Increased by Glucosamine under Normal Glucose Conditions but Is Inhibited by Glucosamine under High Glucose Conditions in Macrophage Cells.
P2860
Q26752842-5D074A2C-76AC-404B-8338-CDFDF3715C10Q26773988-4865ABC4-3B35-4F27-83B8-5706DBBA0295Q28084020-76776804-4E04-4F6E-A50A-3C942CA13E64Q28085402-BF79E58E-37CD-49D8-A94D-50C048F85D56Q33361067-FB2E7F74-8FCC-4E71-AC59-1007275CDE30Q33849720-1482F5CE-2432-4A11-802F-09FFD8DD7D74Q34426366-0D147AFE-9B2B-4B7B-84B3-6E4F43F7FF97Q34620863-56AFE54D-9B96-4573-BD26-AA3EE5708D6AQ35970441-90A4A17B-B880-42A8-B18D-4B827E94BD71Q36041756-C96577BF-AB2C-46D1-BE27-49251BC2561DQ36096719-EF6CE7AF-D293-46A7-9178-2A71268B1A76Q36184305-FD53C247-AAA3-4AE7-B2E2-A2AE4EFAD464Q36310290-1E2DB7CE-EA77-43CB-AEFC-2FCABDD8C995Q36427543-27D30255-DB04-4468-B111-C94C87A1451EQ36733765-97160F47-697A-4747-97AA-2D8CC9DAAE88Q36957711-AA5AE89A-B5D5-4B74-846A-75B229DAEB69Q37076909-35A78C49-DB8A-4ECB-BE46-EE23F9838C23Q37660911-F4F1DEAD-A5F8-4DE9-B8AC-A0C65F1818E0Q38170004-149C0066-3855-4E29-8739-6057927CAF10Q38184231-D3A11DB2-AFF0-4D99-AFCB-3250F31C71EEQ38193224-2A4C01F8-C732-4D0A-A32C-00AD1DDB70A2Q38237575-D0CFB140-B7F3-4916-A53E-1CA6996AE908Q38247344-B1883A40-DB91-4A01-AB9D-F2FC11B30C06Q38272067-F52064DB-705D-42FD-9DE9-D5E2514255D2Q38335167-97657975-7FC4-4AE7-9890-73EAB3AAE373Q38533861-B669C54A-B73E-488C-9ED9-39476EDEB34DQ38860494-79E8D604-BFD0-4558-82C5-11B28FD4327CQ38891199-5940C41F-DD26-4A51-B2A7-3B659191A5F2Q38905346-4010FCD3-E219-427A-B0DE-11A19B83BC63Q41122443-C10DC658-511E-4A00-9CD7-52E4D95A7A44Q41189292-FE41301A-7941-4C68-88CD-FB30A084A4E5Q41276922-D4FE723B-598F-4B69-8C01-2F8BA54DB638Q45340249-E0E26281-876C-4F50-B89C-2979DEEFBC7DQ45985041-1A96EBD5-4F9E-4F1F-92C6-3B31193847D3Q47100126-74900ADA-6441-465B-B523-79C479E03D35Q47120089-D5928932-C48D-42F8-8277-C4EFD5BEB769Q47445493-82DB6956-A6FB-4928-B025-F306F395D6A6Q47617036-E2E70F46-B233-40E8-BDB4-D921BF8B7BE4Q48103560-CB1447D1-4439-4CDD-A64C-2DA0953711E1Q48402759-0A5EAFEC-7CFE-4074-87E3-A76C8A6615E1
P2860
Protein O-GlcNAcylation in diabetes and diabetic complications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Protein O-GlcNAcylation in diabetes and diabetic complications.
@en
type
label
Protein O-GlcNAcylation in diabetes and diabetic complications.
@en
prefLabel
Protein O-GlcNAcylation in diabetes and diabetic complications.
@en
P2860
P1476
Protein O-GlcNAcylation in diabetes and diabetic complications.
@en
P2093
Gerald W Hart
Junfeng Ma
P2860
P304
P356
10.1586/14789450.2013.820536
P577
2013-08-01T00:00:00Z